Trauma: Clinical Trials

4 trials for Trauma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 4

Follow Trauma: new trials by email Literature Review of Trauma trials Research Report on Trauma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Helping Children With Trauma
Trauma Systems Therapy (TST), Treatment as Usual (TAU) - Trauma, Post-Traumatic Stress Disorder
Phase 3TerminatedNYU Langone Health142016-02-012017-03-31
Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture
C1-esterase inhibitor, Saline 0.9% - Trauma, Inflammation
Phase 3TerminatedUMC Utrecht112012-04-012015-02-04
Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding
eptacog alfa (activated), placebo - Acquired Bleeding Disorder, Trauma
Phase 3TerminatedNovo Nordisk A/S5542005-10-012014-06-25
Impact Of Antioxidant Micronutrients On Intensive Care Unit (ICU) Outcome
Selenium (Se), Zinc (Zn), Vitamin C, Vitamin B1, Vitamin E, Placebo - Critically Ill Patients, Cardiac Surgery
Phase 3TerminatedCentre Hospitalier Universitaire Vaudois2002003-01-012010-07-30

Narrower conditions

Wounds and Injuries (4)  ·  Angioedemas, Hereditary (1)  ·  Critical Illness (1)  ·  Inflammation (1)  ·  Multiple Organ Failure (1)  ·  Sepsis (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Subarachnoid Hemorrhage (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Angioedema (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemorrhage (1)  ·  Hereditary Complement Deficiency Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)

Interventions

Ascorbic Acid (1)  ·  Complement C1 Inhibitor Protein (1)  ·  Factor VII (1)  ·  Selenium (1)  ·  Sodium Chloride (1)  ·  Solutions (1)  ·  Therapeutics (1)  ·  Thiamine (1)  ·  Vitamin E (1)  ·  Zinc (1)

Sponsors

Centre Hospitalier Universitaire Vaudois (1)  ·  NYU Langone Health (1)  ·  Novo Nordisk A/S (1)  ·  UMC Utrecht (1)

Countries

Netherlands (2)  ·  Switzerland (2)  ·  United States (2)  ·  Brazil (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Italy (1)  ·  South Africa (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Glenn Saxe, MD (1)  ·  Luke P Leenen, MD, PhD (1)  ·  Mette M Berger, MD PhD (1)

Results publications

PMID 18687132, PMID 21988742

NIH funding

2005 (1)